Literature DB >> 26700816

TNF-α Inhibits FoxO1 by Upregulating miR-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells during Osteoporosis.

Li Liao1,2,3, Xiaoxia Su1,4, Xiaohong Yang1,5, Chenghu Hu1,3, Bei Li1,2,3, Yajie Lv6, Yi Shuai1,2,3, Huan Jing1,2,3, Zhihong Deng7, Yan Jin1,3.   

Abstract

Decline of antioxidant defense after estrogen deficiency leads to oxidative damage in bone marrow-derived mesenchymal stem cells (BMMSCs), resulting a defect of bone formation in osteoporosis. Forkhead box O1 (FoxO1) protein is crucial for defending physiological oxidative damage in bone. But whether FoxO1 is involved in the oxidative damage during osteoporosis is largely unknown. In this study, we found that FoxO1 protein accumulation was decreased in BMMSCs of ovariectomized mice. The decrease of FoxO1 resulted in the suppression of manganese superoxide dismutase (Sod2) and catalase (Cat) expression and accumulation of reactive oxygen species (ROS), inhibiting the osteogenic differentiation of BMMSCs. The decline of FoxO1 protein was caused by tumor necrosis factor-alpha (TNF-α) accumulated after estrogen deficiency. Mechanistically, TNF-α activated NF-κB pathway to promote microRNA-705 expression, which function as a repressor of FoxO1 through post-transcriptional regulation. Inhibition of NF-κB pathway or knockdown of miR-705 largely prevented the decline of FoxO1-mediated antioxidant defense caused by TNF-α and ameliorated the oxidative damage in osteoporotic BMMSCs. Moreover, the accumulated ROS further activated NF-κB pathway with TNF-α, which formed a feed-forward loop to persistently inhibiting FoxO1 protein accumulation in BMMSCs. In conclusion, our study revealed that the decline of FoxO1 is an important etiology factor of osteoporosis and unclosed a novel mechanism of FoxO1 regulation by TNF-α. These findings suggested a close correlation between inflammation and oxidative stress in stem cell dysfunction during degenerative bone diseases.
© 2015 AlphaMed Press.

Entities:  

Keywords:  Differentiation; Mesenchymal stem cells; Osteoporosis; Stem cell-microenvironment; miRNA

Mesh:

Substances:

Year:  2016        PMID: 26700816     DOI: 10.1002/stem.2274

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  37 in total

Review 1.  MicroRNAs in bone diseases.

Authors:  L Gennari; S Bianciardi; D Merlotti
Journal:  Osteoporos Int       Date:  2016-11-30       Impact factor: 4.507

Review 2.  Exercise to Mend Aged-tissue Crosstalk in Bone Targeting Osteoporosis & Osteoarthritis.

Authors:  Sarah E Little-Letsinger; Janet Rubin; Brian Diekman; Clinton T Rubin; Cody McGrath; Gabriel M Pagnotti; Eric L Klett; Maya Styner
Journal:  Semin Cell Dev Biol       Date:  2021-09-04       Impact factor: 7.727

3.  Immunometabolic Endothelial Phenotypes: Integrating Inflammation and Glucose Metabolism.

Authors:  Wusheng Xiao; William M Oldham; Carmen Priolo; Arvind K Pandey; Joseph Loscalzo
Journal:  Circ Res       Date:  2021-04-23       Impact factor: 17.367

Review 4.  A narrative overview of utilizing biomaterials to recapitulate the salient regenerative features of dental-derived mesenchymal stem cells.

Authors:  Sevda Pouraghaei Sevari; Sahar Ansari; Alireza Moshaverinia
Journal:  Int J Oral Sci       Date:  2021-06-30       Impact factor: 6.344

5.  Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy.

Authors:  Li Liao; Bingzheng Shi; Heran Chang; Xiaoxia Su; Lichao Zhang; Chunsheng Bi; Yi Shuai; Xiaoyan Du; Zhihong Deng; Yan Jin
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

6.  Melatonin suppresses autophagy in type 2 diabetic osteoporosis.

Authors:  Wei-Lin Zhang; Hong-Zheng Meng; Rui-Fei Yang; Mao-Wei Yang; Guang-Hong Sun; Jun-Hua Liu; Peng-Xu Shi; Fei Liu; Bo Yang
Journal:  Oncotarget       Date:  2016-08-09

7.  Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis.

Authors:  Xiao Chen; Xin Zhi; Liehu Cao; Weizong Weng; Panpan Pan; Honggang Hu; Chao Liu; Qingjie Zhao; Qirong Zhou; Jin Cui; Jiacan Su
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469

8.  Silencing Proteasome 26S Subunit ATPase 2 (PSMC2) Protects the Osteogenic Differentiation In Vitro and Osteogenesis In Vivo.

Authors:  Bin Zhou; Kun Peng; Guoqiang Wang; Weihua Chen; Yijun Kang
Journal:  Calcif Tissue Int       Date:  2021-02-24       Impact factor: 4.333

9.  Insulin receptor substrate-1 time-dependently regulates bone formation by controlling collagen Iα2 expression via miR-342.

Authors:  Yue Guo; Chen-Yi Tang; Xiao-Fei Man; Hao-Neng Tang; Jun Tang; Fang Wang; Ci-La Zhou; Shu-Wen Tan; Yun-Zhi Feng; Hou-De Zhou
Journal:  FASEB J       Date:  2016-09-13       Impact factor: 5.191

10.  Oxidative stress induces imbalance of adipogenic/osteoblastic lineage commitment in mesenchymal stem cells through decreasing SIRT1 functions.

Authors:  Chia-Hua Lin; Nan-Ting Li; Hui-Shan Cheng; Men-Luh Yen
Journal:  J Cell Mol Med       Date:  2017-10-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.